NASDAQ:BRKR - Bruker Stock Price, Forecast & News

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Bruker announced a quarterly dividend on Thursday, November 14th. Stockholders of record on Monday, December 2nd will be paid a dividend of $0.04 per share on Friday, December 20th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.30%. The ex-dividend date of this dividend is Friday, November 29th. View Bruker's Dividend History.

Bruker Co. (NASDAQ:BRKR) announced its quarterly earnings results on Thursday, October, 31st. The medical research company reported $0.43 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.38 by $0.05. The medical research company had revenue of $521.10 million for the quarter, compared to analyst estimates of $493.52 million. Bruker had a net margin of 10.20% and a return on equity of 28.02%. The business's revenue for the quarter was up 11.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.37 earnings per share. View Bruker's Earnings History.

Bruker is scheduled to release their next quarterly earnings announcement on Monday, February 10th 2020. View Earnings Estimates for Bruker.

13 analysts have issued 12 month target prices for Bruker's stock. Their forecasts range from $39.00 to $60.00. On average, they expect Bruker's share price to reach $50.58 in the next year. This suggests that the stock has a possible downside of 4.2%. View Analyst Price Targets for Bruker.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 4 hold ratings, 8 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bruker.

News stories about BRKR stock have trended negative recently, according to InfoTrie Sentiment. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Bruker earned a coverage optimism score of -2.6 on InfoTrie's scale. They also gave media headlines about the medical research company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Bruker.

Some companies that are related to Bruker include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), BIO-TECHNE (TECH), Charles River Laboratories Intl. (CRL), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include Alibaba Group (BABA), NeoGenomics (NEO), Netflix (NFLX), AbbVie (ABBV), Costco Wholesale (COST), Intel (INTC), Nike (NKE), AT&T (T), Thermo Fisher Scientific (TMO) and Amgen (AMGN).

Bruker's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Boston Trust Walden Corp (0.33%), Scout Investments Inc. (0.16%), Mckinley Capital Management LLC Delaware (0.06%), Calamos Advisors LLC (0.01%), Nisa Investment Advisors LLC (0.01%) and Lipe & Dalton (0.01%). Company insiders that own Bruker stock include Burkhard Prause, Frank H Laukien, Marc A Kastner and Mark Munch. View Institutional Ownership Trends for Bruker.

BRKR stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc., Nisa Investment Advisors LLC, Campbell & CO Investment Adviser LLC and NEXT Financial Group Inc. Company insiders that have sold Bruker company stock in the last year include Burkhard Prause, Frank H Laukien, Marc A Kastner and Mark Munch. View Insider Buying and Selling for Bruker.

BRKR stock was bought by a variety of institutional investors in the last quarter, including Mckinley Capital Management LLC Delaware, Boston Trust Walden Corp, Lipe & Dalton, Zurcher Kantonalbank Zurich Cantonalbank , Huntington National Bank, Calamos Advisors LLC and Global Retirement Partners LLC. View Insider Buying and Selling for Bruker.

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BRKR stock can currently be purchased for approximately $52.82.

Bruker has a market capitalization of $8.13 billion and generates $1.90 billion in revenue each year. The medical research company earns $179.70 million in net income (profit) each year or $1.40 on an earnings per share basis. Bruker employs 6,870 workers across the globe.View Additional Information About Bruker.

The official website for Bruker is http://www.bruker.com/.

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]